A critical look at pharma coverage

Today is FiercePharma second edition of Industry Voices. As previously announced, we're bringing you a variety of outside columnists to discuss issues affecting the pharmaceutical industry and examine the trends that are changing the way drugmakers do business.

Our second columnist is Robert Goldberg, a blogger with DrugWonks. DrugWonks is the blog of the Centers for Medicine in the Public Interest (CMPI), which debates today's drug policies. Scroll down or click here to check out his thoughts on the future of the pharmaceutical industry and the media's coverage of drug safety issues. - Maureen

Suggested Articles

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.